Doxepin
Doxepin, PRUDOXIN, Silenor, Zonalon
Tricyclic Antidepressant
NADAC/unit
$0.0783
No Shortage
Tier 1: 184.5%
PA Req: 202.1%
25 Manufacturers
102 ANDAs
Doxepin treats depression and chronic pain by blocking reuptake of serotonin and norepinephrine.
vs. brand Doxepin: Generic saves up to 99% per unit
Market Intelligence
2025-08-13 Class II Recall: Alembic Pharmaceuticals Limited
Generic Manufacturers
ACTAVIS ELIZABETH LLCAIPING PHARMACEUTICAL INCAJANTA PHARMA LTDALEMBIC PHARMACEUTICALS LTDAMNEAL PHARMACEUTICALS CO GMBHAMNEAL PHARMACEUTICALS LLCAPPCO PHARMA LLCAUROBINDO PHARMA LTDCHARTWELL RX SCIENCES LLCCURRAX PHARMACEUTICALS LLCEPIC PHARMA LLCIXORA LIFESCIENCE LLPJUBILANT CADISTA PHARMACEUTICALS INCLANNETT CO INCMANKIND PHARMA LTDMICRO LABS LTDMSN LABORATORIES PRIVATE LTDMYLAN PHARMACEUTICALS INCPH HEALTH LTDPTS CONSULTING LLCRK PHARMA INCSTRIDES PHARMA INTERNATIONAL AGTARO PHARMACEUTICAL INDUSTRIES LTDTEVA PHARMACEUTICALS DEVELOPMENT INCVELZEN PHARMA PVT LTDZYDUS LIFESCIENCES LTD
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.